MusclePharm Schedules 2015 Third Quarter Financial Results
DENVER--(BUSINESS WIRE)-- MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company, will report its financial results for the third quarter that ended September 30, 2015 on Monday, November 9, 2015, following market close.
The Company will conduct a conference call the following morning, Tuesday, November 10, at 8:00 a.m. Eastern Time/5:00 a.m. Pacific Time.
2015 Third Quarter Conference Call Information
When:Tuesday, November 10, 2015Time:8:00 a.m. Eastern TimePhone:(800) 860-2442 (domestic)(412) 858-4600 (international)
A live webcast will be available online on MusclePharm's website at http://ir.musclepharmcorp.com/, where it will be archived for one year.
An audio replay of the conference call will be available through midnight November 17, 2015 by dialing (877) 344-7529 from the U.S. or Canada, or (412) 317-0088 from international locations, passcode 10076071.
About MusclePharm Corporation
MusclePharm® is a scientifically driven, performance lifestyle company that currently develops, manufactures, markets and distributes branded nutritional supplements. The company offers a complete range of powders, capsules, tablets and gels. Its portfolio of recognized brands, including MusclePharm® Hybrid and Core Series, Arnold Schwarzenegger Series™ and FitMiss™, are marketed and sold in more than 120 countries and available in over 45,000 retail outlets globally. These clinically-proven and scientific nutritional supplements are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors and universities. MusclePharm is the innovator of the sports nutrition industry. For more information, visit http://www.musclepharm.com.
Follow MusclePharm Corporation on Facebook, Twitter, and Instagram.
To sign up to receive MusclePharm news via email, please visit http://ir.musclepharmcorp.com/email-alerts
View source version on businesswire.com: http://www.businesswire.com/news/home/20151105006769/en/
Media:
Sitrick and Company
Seth Lubove, (310) 788-2850
[email protected]
Source: MusclePharm Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
- Strategy to report Q2 2026 results on July 30
- Nootropics Depot CEO Paul Eftang Calls for New Reishi Bioactive Standardization Paradigm
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share